Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Heart failure in 2013

Continue what we are doing to treat HF, but do it better

Nature Reviews Cardiology volume 11, pages 69–70 (2014)Cite this article

Subjects

In 2013, clinical trials in heart failure focused on drugs and devices that might improve treatment of symptomatic patients beyond standard therapy. None achieved this aim. Therefore, future efforts should emphasize increased adherence to current, evidence-based therapy, and trials might better address efforts to prevent, rather than treat, heart failure.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The natural history of heart failure exhibits age-dependent progression of left ventricular remodelling, with the development of symptoms and premature death.

References

  1. Cohn, J. N. Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition. Circulation 91, 2504–2507 (1995).

    Article  CAS  Google Scholar 

  2. Bristow, M. R. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140–2150 (2004).

    Article  CAS  Google Scholar 

  3. Chen, H. H. et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA http://dx.doi.org/10.1001/jama.2013.282190.

  4. Ruschitzka, F. et al. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N. Engl. J. Med. 369, 1395–1405 (2013).

    Article  CAS  Google Scholar 

  5. Redfield, M. M. et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309, 1268–1277 (2013).

    Article  CAS  Google Scholar 

  6. Swedberg, K. et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376, 875–885 (2010).

    Article  CAS  Google Scholar 

  7. Kosmala, W. et al. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J. Am. Coll. Cardiol. 62, 1330–1338 (2013).

    Article  CAS  Google Scholar 

  8. Pitt, B. et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341, 709–717 (1999).

    Article  CAS  Google Scholar 

  9. Edelmann, F. et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309, 781–791 (2013).

    Article  CAS  Google Scholar 

  10. Pfeffer, M. A. Treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT). Presented at the American Heart Association Scientific Sessions 2013.

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, University of Minnesota Medical School, Mayo Mail Code 508, 420 Delaware Street Southeast, Minneapolis, 55455, MN, USA

    Jay N. Cohn

Authors
  1. Jay N. Cohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jay N. Cohn.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohn, J. Continue what we are doing to treat HF, but do it better. Nat Rev Cardiol 11, 69–70 (2014). https://doi.org/10.1038/nrcardio.2013.212

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.212

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing